Atlas Trials

Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53

RecordFirmDate
p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246 (NCT02098343)Aprea Therapeutics2014-03-01

Track Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 automatically

Every clearance here is in the API, with alerts when new ones post.